New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...

Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta. The FDA approved low-dose, preservative-free Qlosi (pilocarpine HCl ophthalmic solution) 0.4% in October 2023 ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay ...

Visionary Ventures, while also not securing deals in OC, recorded eight deals during 2024 that included $65 million financing into ONL Therapeutics, $78 million into Orasis Pharmaceuticals and $75 ...

Novo Nordisk will outlay $6.5bn in 2025 to ramp up production in the US. Image credit: Shutterstock / KK Stock. Compounders are on alert after the US Food and Drug Administration (FDA) declared the ...